Three clonally related T-cell lymphoma lines (PB-1, 2A, and 2B) were examined for
expression of IL-2, IL-4, and their receptors. All three lines were derived from a single patient …

The expression of the interleukin-4 receptor on human blood and tonsil lymphocytes has
been studied using a monoclonal antibody and high-sensitivity immunofluorescence flow …

A continuous cell line was established from the blood of a patient (HH) with an aggressive
cutaneous T‐cell leukemia/lymphoma who lacked antibodies to human T lymphotrophic …

We investigated the expression of interleukin‐2 receptors (IL‐2R) in 60 adult patients with
mature lymphoid neoplasms by flow cytometric analysis, using two monoclonal antibodies …

IL-2 is a major growth factor for all T-cell subsets acting via a specific membrane receptor. To
investigate its role in the pathogenesis of cutaneous T-cell lymphomas (CTCLs), we …

In particular, interleukin-4 (IL-4) prevents B-CLL cell clones from entering spontaneous
apoptosis by increasing the expression of bcl-25 and protects B-CLL cells against anti-APO1 …

Abstract Keratinocyte-derived interleukin-7 (IL-7) is a potent growth factor for some
cutaneous T-cell lymphomas (CTCL). We investigated the expression of IL-7 receptor (IL …

Sézary syndrome is a cutaneous T cell lymphoma characterized by infiltration of the skin by
CD4+ cells. These cells generally respond poorly to mitogens and T cell activators. We have …

We studied the expression of the receptor of interleukin (IL)‐4, one of the T cell growth
factors, on fresh peripheral blood leukemic cells from adult T‐cell leukemia (ATL) patients …

The cytokine secreted by a human hybrid B cell line (STS 25) obtained by fusion of the B
lymphoblastoid cell line WI-L2-729-HF2 with neoplastic B cells from a patient with B cell non …